Cezary Cybulski

Also affiliated with Pomeranian Medical University, Mississippi State University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.751Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

The Journal of Pathology Clinical Research(2023)10.1002/cjp2.311

Top 27%

0.751DataRank

Top 27%28 citations

Eunyoung Kang, Ashley Weir, Peter Rambau, Cheng‐Han Lee, Gregg Nelson +95 more

Papers

Driven by 28 papers — median percentile 73. Top paper: “Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)”.

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0103

N/A

1.8DataRank · unranked

76 citations

Joshy George, Chen Wang, Timothy Budden, Tuan Zea Tan, Derek S. Chiu +134 more

CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

Cancer(2022)10.1002/cncr.34582

N/A

1.2DataRank · unranked

46 citations

Ashley Weir, Nicola S. Meagher, Kyo Farrington, Gregg Nelson, Prafull Ghatage +95 more

Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

Nature Genetics(2023)10.1038/s41588-023-01534-4

N/A

0.753DataRank · unranked

150 citations

Jiayi Shen, Alex A Rodriguez, Edward J. Saunders, Fei Chen, Rohini Janivara +95 more

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

The Journal of Pathology Clinical Research(2023)10.1002/cjp2.311

Top 27%

0.751DataRank

Top 27%28 citations

Eunyoung Kang, Ashley Weir, Peter Rambau, Cheng‐Han Lee, Gregg Nelson +95 more

Prognostic gene expression signature for high-grade serous ovarian cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.05.019

N/A

0.718DataRank · unranked

119 citations

S. Chen, Blake Gilks, C. Wang, S.C.Y. Leung, V. Chow +387 more

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1206

N/A

0.464DataRank · unranked

21 citations

Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon, Chi Nam Ignatius Pang, Derek S. Chiu +95 more

KLK3 SNP–SNP interactions for prediction of prostate cancer aggressiveness

Scientific Reports(2021)10.1038/s41598-021-85169-7

N/A

0.416DataRank · unranked

15 citations

Po‐Yu Huang, Chia‐Ho Cheng, Heng-Yuan Tung, Zhide Fang, Anders Berglund +42 more

Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

British Journal of Cancer(2022)10.1038/s41416-022-02014-y

N/A

0.312DataRank · unranked

7 citations

Eunyoung Kang, Nicola S. Meagher, Gregg Nelson, Prafull Ghatage, Cheng‐Han Lee +88 more

Concurrent RB1 loss and BRCA -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma

medRxiv(2023)10.1101/2023.11.09.23298321

N/A

0.269DataRank · unranked

5 citations

Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Tibor A. Zwimpfer +94 more

Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer

Prostate Cancer and Prostatic Diseases(2021)10.1038/s41391-020-00311-2

N/A

0DataRank · unranked

25 citations

Roshan Karunamuni, APCB BioResource (Australian Prostate Cancer BioResource), Canary PASS Investigators, Minh‐Phuong Huynh‐Le, Chun Chieh Fan +63 more

The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

Cancers(2020)10.3390/cancers12113254

N/A

0DataRank · unranked

24 citations

Paula Paulo, Sofia Maia, Manuela Pinheiro, Ana Peixoto, Marta Cardoso +57 more

Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma

medRxiv(2021)10.1101/2021.09.16.21262993

N/A

0DataRank · unranked

4 citations

Tayyebeh M. Nazeran, Sandra Lee, Pauline Krämer, Evan S. Cairns, Derek S. Chiu +77 more

A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data

Cancer Epidemiology Biomarkers & Prevention(2020)10.1158/1055-9965.epi-19-1527

N/A

0DataRank · unranked

39 citations

Chun Chieh Fan, Roshan Karunamuni, Eleanor Walsh, Emma L. Turner, J. Athene Lane +57 more

Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

Genetic Epidemiology(2020)10.1002/gepi.22288

N/A

0DataRank · unranked

45 citations

Alexander Gusev, Bogdan Paşaniuc, Lang Wu, Jirong Long, Zomoroda Abu-Full +95 more

An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

Nature Communications(2020)10.1038/s41467-020-17673-9

N/A

0DataRank · unranked

246 citations

Yaohua Yang, Xingyi Guo, Xiao‐Ou Shu, Qiuyin Cai, Xiang Shu +80 more

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Nature Genetics(2020)10.1038/s41588-019-0537-1

N/A

0DataRank · unranked

189 citations

Laura Fachal, EMBRACE Collaborators, KConFab Investigators, HEBON Investigators, ABCTB Investigators +95 more

Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis

Diabetologia(2023)10.1007/s00125-023-05925-4

N/A

0DataRank · unranked

38 citations

Emmanouil Bouras, Andrei‐Emil Constantinescu, Kimberley Burrows, Caroline J. Bull, Emma E. Vincent +92 more

Site-saturation functional screens identify PALB2 missense variants associated with increased breast cancer risk

Nature Communications(2026)10.1038/s41467-025-67252-z

N/A

0DataRank · unranked

0 citations

Sabine C. Knaup, Roberta Menafra, Merel E. Braspenning, Magdalena B. Rother, Petra Kleiblova +78 more

Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry

The American Journal of Human Genetics(2023)10.1016/j.ajhg.2023.05.010

N/A

0DataRank · unranked

25 citations

Jiayi Shen, Ravi Madduri, Alexis Rodriguez, Yukai Xiao, Xin Sheng +95 more

Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study

British Journal of Cancer(2023)10.1038/s41416-023-02489-3

N/A

0DataRank · unranked

8 citations

Tomas I. Gonzales, Tessa Strain, Pedro F. Saint‐Maurice, D. Timothy Bishop, Stephen J. Chanock +89 more

Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry

medRxiv(2023)10.1101/2023.05.12.23289860

N/A

0DataRank · unranked

2 citations

Jiayi Shen, Ravi Madduri, Alexis Rodriguez, Yukai Xiao, Xin Sheng +95 more

Germline variation at 8q24 and prostate cancer risk in men of European ancestry

UNC Libraries(2023)10.17615/ejg2-ya10

N/A

0DataRank · unranked

0 citations

Victoria L. Stevens, Kan Wang, Nawaid Usmani, Radka Kaneva, C.A. Haiman +73 more

Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3552

N/A

0DataRank · unranked

14 citations

Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Tibor A. Zwimpfer +93 more

Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.05.013

N/A

0DataRank · unranked

2 citations

Lauren Borho, Sarah E. Taylor, Linda E Kelemen, Anna deFazio, Penelope M. Webb +64 more

The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1

Current Oncology(2025)10.3390/curroncol32120705

N/A

0DataRank · unranked

2 citations

Adriana Ionelia Apostol, Kelly Metcalfe, Dimitri Jorgji, Cezary Cybulski, Jacek Gronwald +19 more

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA -deficient tubo-ovarian high-grade serous carcinoma

medRxiv(2025)10.1101/2025.09.17.25335919

N/A

0DataRank · unranked

0 citations

Sián Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa Jayawardana, Laura Twomey +95 more

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

Nature Genetics(2021)10.1038/s41588-020-00748-0

N/A

0DataRank · unranked

502 citations

Burcu F. Darst, Lilit C. Moss, Edward J. Saunders, Xin Sheng, Alisha Chou +95 more

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma

Research Square(2025)10.21203/rs.3.rs-7572112/v1

N/A

0DataRank · unranked

0 citations

Tibor A. Zwimpfer, Sián Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa Jayawardana +95 more

Cezary Cybulski

Indexed papers

Top data-sharing exemplar

Papers